Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002576651 | SCV002936554 | likely benign | Nemaline myopathy 2 | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004651983 | SCV005146330 | uncertain significance | Inborn genetic diseases | 2024-05-20 | criteria provided, single submitter | clinical testing | The c.2338G>A (p.E780K) alteration is located in exon 25 (coding exon 23) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 2338, causing the glutamic acid (E) at amino acid position 780 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |